FDA Import Refusal 1FX-3134629-0/10002/1 — Sanofi India Ltd
The FDA refused shipment 1FX-3134629-0/10002/1 from Sanofi India Ltd (India) on Sep 14, 2026. The refused product falls under Drugs and Biologics — GLYBURIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA11 GLYBURIDE (ANTI-DIABETIC)
- Charges
- 75